Pharma Mar S.A. (PHM) — Tangible Net Worth Ratio
Pharma Mar S.A. (PHM) has a Tangible Net Worth Ratio of 98.6% as of December 2025. This metric is calculated by deducting intangible assets (€3.55 Million) from net assets (€251.83 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PHM current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pharma Mar S.A. Tangible Net Worth Ratio (2002–2025)
This chart shows how Pharma Mar S.A.'s Tangible Net Worth Ratio has changed across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 98.6%, reflecting net assets of €251.83 Million with intangible assets of €3.55 Million EUR. See Pharma Mar S.A. (PHM) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Pharma Mar S.A. (2002–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Pharma Mar S.A. from 2002 to 2025, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Pharma Mar S.A. market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.6% | €251.83 Million | €3.55 Million | €395.08 Million | ▼ -0.9 pp |
| 2024 | 99.5% | €208.36 Million | €1.00 Million | €349.64 Million | ▲ +0.5 pp |
| 2023 | 99.0% | €193.44 Million | €1.94 Million | €340.52 Million | ▲ +0.2 pp |
| 2022 | 98.8% | €222.96 Million | €2.59 Million | €393.26 Million | ▲ +0.7 pp |
| 2021 | 98.2% | €177.92 Million | €3.23 Million | €368.39 Million | ▲ +1.9 pp |
| 2020 | 96.2% | €102.72 Million | €3.86 Million | €330.26 Million | ▲ +77.7 pp |
| 2019 | 18.5% | €7.46 Million | €6.07 Million | €124.70 Million | ▲ +13.9 pp |
| 2018 | 4.7% | €17.47 Million | €16.66 Million | €157.68 Million | ▼ -7.4 pp |
| 2017 | 12.1% | €22.98 Million | €20.21 Million | €187.72 Million | ▼ -36.6 pp |
| 2016 | 48.7% | €48.49 Million | €24.90 Million | €221.14 Million | ▼ -14.6 pp |
| 2015 | 63.3% | €73.04 Million | €26.83 Million | €211.94 Million | ▲ +7.0 pp |
| 2014 | 56.2% | €60.07 Million | €26.29 Million | €201.39 Million | ▲ +1.9 pp |
| 2013 | 54.3% | €49.44 Million | €22.59 Million | €189.37 Million | ▲ +5.3 pp |
| 2012 | 49.0% | €38.73 Million | €19.74 Million | €199.83 Million | ▼ -0.8 pp |
| 2011 | 49.8% | €34.50 Million | €17.32 Million | €217.82 Million | ▼ -8.8 pp |
| 2010 | 58.6% | €34.86 Million | €14.45 Million | €230.82 Million | ▼ -11.0 pp |
| 2009 | 69.5% | €41.14 Million | €12.53 Million | €211.31 Million | ▼ -6.6 pp |
| 2008 | 76.1% | €49.34 Million | €11.77 Million | €207.54 Million | ▼ -12.8 pp |
| 2007 | 88.9% | €98.81 Million | €10.92 Million | €232.33 Million | ▼ -1.0 pp |
| 2006 | 89.9% | €107.17 Million | €10.82 Million | €224.41 Million | ▼ -10.1 pp |
| 2005 | 100.0% | €360.04 Million | €162.00K | €393.72 Million | ▲ +0.0 pp |
| 2004 | 100.0% | €301.23 Million | €149.00K | €337.34 Million | ▲ +7.4 pp |
| 2003 | 92.6% | €139.28 Million | €10.31 Million | €275.47 Million | ▼ -6.6 pp |
| 2002 | 99.1% | €166.90 Million | €1.42 Million | €271.43 Million | — |